| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | Chief Operations Officer | Common Stock | 55.2K | $182K | $3.30 | May 12, 2025 | Direct |
| Cartesian Therapeutics, Inc. | Chief Operations Officer | Stock Option (Right to Buy) | 34.4K | $39K | $0.79 | May 12, 2025 | Direct |
| Cartesian Therapeutics, Inc. | Chief Operations Officer | Employee Stock Option (right to buy) | 47.4K | Jan 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | May 12, 2025 | 2 | $24.8K | 4 | May 14, 2025 | Chief Operations Officer |
| RNAC | Cartesian Therapeutics, Inc. | Apr 15, 2025 | 2 | $24.8K | 4 | Apr 16, 2025 | Chief Operations Officer |
| RNAC | Cartesian Therapeutics, Inc. | Jan 3, 2025 | 2 | -$30.1K | 4 | Jan 7, 2025 | Chief Operations Officer |
| RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2025 | 2 | $0 | 4 | Jan 6, 2025 | Chief Operations Officer |
| RNAC | Cartesian Therapeutics, Inc. | Dec 26, 2024 | 2 | $25.2K | 4 | Dec 30, 2024 | SVP, Head of Manufacturing |
| RNAC | Cartesian Therapeutics, Inc. | Apr 9, 2024 | 0 | $0 | 3 | Apr 19, 2024 | SVP, Head of Manufacturing |